Coronavirus vaccine | Pfizer could get U.K. approval this week, says Telegraph

U.S. Food and Drug Administration said on Friday that it would meet on December 10 to discuss whether to authorise the vaccine.

November 23, 2020 02:50 am | Updated 02:52 am IST - London

This photo provided by Pfizer shows COVID-19 vaccine storage facility in Kalamazoo, Mich.

This photo provided by Pfizer shows COVID-19 vaccine storage facility in Kalamazoo, Mich.

Britain could give regulatory approval to Pfizer-BioNTech's COVID-19 vaccine this week, even before the United States authorises it, the Telegraph news site reported on Sunday.

Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by December 1.

Also read: Coronavirus | Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation

The U.S. Food and Drug Administration said on Friday that it would meet on December 10 to discuss whether to authorise the vaccine.

The U.K. Department of Health had no comment on Sunday on when the first vaccinations would be administered.

Also read: Pfizer seeking emergency use of its COVID-19 vaccine in U.S.

A spokesman said the authorisation process by the medical regulator Medicines and Healthcare Products Regulatory Agency (MHRA) is independent of the government and will take as long as they need to review the final data from Pfizer .

“An enormous amount of planning has taken place to ensure our health service stands ready to roll out a COVID-19 vaccine,” the spokesman added.

Also read: Coronavirus | Israel signs deal with Pfizer for potential COVID-19 vaccine

Britain formally asked its medical regulator, the MHRA, last week to assess the suitability of the Pfizer-BioNTech vaccine.

Britain has ordered 40 million doses and expects to have 10 million doses, enough to protect 5 million people, available by the end of the year if regulators approve it.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.